Nachrichten zur Eli Lilly & Co Aktie

Lilly raises full-year earnings forecasts on surging demand for weight-loss drug

Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster weight-loss drug,…

Eli Lilly raises full-year profit forecast on weight-loss drug strength

Eli Lilly raised its full-year profit forecast on Thursday, betting on surging demand for its blockbuster weight-loss drug, Zepbound, as…

Eli Lilly bricht ein, Novo Nordisk mit Mega-Rebound – das ist der Grund

Paukenschlag im Adipositas-Markt: Das US-amerikanische Pharma-Unternehmen Eli Lilly hat neben den erwarteten Zahlen zum zweiten Quartal frische Studiendaten zur Abnehm-Pille…

Eli Lilly falls after late-stage trial data for oral weight loss therapy

…

Eli Lilly shares tumble on disappointing weight loss drug trial data

Eli Lilly and Co (NYSE:LLY) shares fell more than 10% at the market open as disappointing late-stage trial data for…

Stock Market Today: Dow, S&P 500, Nasdaq Set to Open Up; Trump Tariffs Kick In; Apple, Eli Lilly, Nvidia, AMD, More Movers

Dow, S&P 500, and Nasdaq futures are rising in premarket trading as the stock market digests President Donald Trumps reciprocal…

These 2 stocks are still on our shopping list, and what Eli Lilly needs to deliver on earnings

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Amgen Stock Sinks As Market Eyes MariTides Next Move

Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after…

Eli Lilly earnings are coming Thursday. Heres what top analysts expect

Wall Street is optimistic heading into Eli Lillys second-quarter earnings report.…

Wegovy maker Novo Nordisk warns on continued copycat-drug challenge as new CEO readied

Novo Nordisk cautioned on Wednesday that it expects continued competition this year from copycat versions of its Wegovy obesity drug,…

Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: Whats Going On? - Hims & Hers Health (NYSE:HIMS), Eli Lilly (NYSE:LLY)

Hims & Hers Health Inc. (NYSE: HIMS) plunged 13.1% in Tuesday pre-market after the digital health company reported second-quarter revenue…

Here are the 6 big things were watching in the market in the week ahead

Disney and Eli Lilly are among the six Club stocks reporting in the coming days.…

Eli Lilly stock rises, Novo Nordisk shares jump on potential Medicare coverage By Investing.com

Eli Lilly stock rises, Novo Nordisk shares jump on potential Medicare coverage…

Eli Lilly: The Worst May Be Already Over (Earnings Preview)

…

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo Nordisk.…

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers first choice for patients…

Eli Lilly (LLY) Declines More Than Market: Some Information for Investors

Eli Lilly (LLY) reached $762.95 at the closing of the latest trading day, reflecting a -5.59% change compared to its…

Trumps pharmaceutical tariffs could affect some drugmakers more than others

AbbVie, Bristol Myers Squibb and Eli Lilly appear "relatively well-positioned," while Novartis and Roche look more at risk, TD Cowen…

Lilly set for strong quarter after Novo profit warning

Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival…

Novo Nordisk Stock Implodes: Is Weight-Loss Bubble Bursting? - Hims & Hers Health (NYSE:HIMS), Eli Lilly (NYSE:LLY)

Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a…

EMA empfiehlt Zulassung von weiterem Alzheimer-Medikament

AMSTERDAM/BERLIN (dpa-AFX) - Die europäische Arzneimittelbehörde EMA hat den Weg für ein weiteres Medikament gegen Alzheimer…

How Will Eli Lillys Oncology Drugs Perform in Q2 Earnings?

LLYs oncology sales are expected to have climbed in Q2, led by Verzenio growth, despite pressure from older cancer drugs.…

Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade

Eli Lilly (LLY) closed at $762.18 in the latest trading session, marking a -1.23% move from the prior day.…

Should You Invest in This Under-the-Radar Weight Loss Stock?

Key PointsRhythm Pharmaceuticals lone approved product currently generates minimal sales.However, recent clinical progress could help change that in the coming…

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

Key PointsPresident Trumps tariffs could erode healthcare companies profits, but some may perform well regardless.Eli Lilly and Novartis have taken…

Is Nvidia Stock Too Expensive to Buy Now?

Key PointsData center growth is slated to continue for some time.Nvidias GPUs are unrivaled in the AI space. Many stocks…

Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?

LLYs explosive growth from Mounjaro and Zepbound outpaces MRKs Keytruda-led gains, despite valuation concerns.…

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcickis nonprofit…

Eli Lilly (LLY) Dips More Than Broader Market: What You Should Know

In the most recent trading session, Eli Lilly (LLY) closed at $771.75, indicating a -3.45% shift from the previous trading…

Top Research Reports for Eli Lilly, Netflix & GE Aerospace

LLY, NFLX, and GE lead todays top stock picks, with strong growth drivers but face headwinds from pricing, rivals, and…

3 Dividend Growth Stocks to Buy and Hold

Key PointsAbbott Laboratories is a dividend growth machine thats known for consistency.AbbVies dividend has more than quadrupled since 2013.Eli Lilly…

Can Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?

LLY rides high on surging demand for Mounjaro and Zepbound, now nearly half its revenues ahead of Q2 earnings.…

Eli Lilly Comes Out As ADA Winner

…

3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly

Key PointsNovo Nordisks beaten-down valuation became too attractive to pass up, so I bought the stock earlier this year.Eli Lillys…

Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know

In the most recent trading session, Eli Lilly (LLY) closed at $786.92, indicating a +1.19% shift from the previous trading…

Eli Lilly Q2 preview: BofA sees focus on policy risks, obesity pipeline

Bank of America on Wednesday reiterated its “Buy” rating and $1,000 price objective on Eli Lilly and Co (NYSE:LLY), ahead…

3 Underrated Dividend Growth Stocks to Buy and Hold for Years

Key PointsThe stocks listed here each increased their dividend payments by more than 10% recently.Although their yields may look unimpressive,…

3 No-Brainer Stocks to Buy in July

Key PointsAbbVie offers something for every investor.Eli Lilly could be overdue for a big rally.Vertex Pharmaceuticals is in a new…

Better Growth Buy: Eli Lilly vs. Viking Therapeutics @themotleyfool #stocks $LLY $GS $NVO $VKTX

…

Better Growth Buy: Eli Lilly vs. Viking Therapeutics

Key PointsEli Lilly is a leader in the weight loss drug market, generating blockbuster revenue.Viking Therapeutics recently launched a phase…

2 Stocks to Buy on the Dip and Hold for 10 Years

Key PointsNovo Nordisks shares look attractive after a terrible performance over the past 12 months.DexCom has significant room to grow…

2 Dividend Growth Stocks to Buy and Hold Forever

Key PointsInvesting in attractive dividend growth stocks can lead to superior long-term returns.The two healthcare companies below generally deliver excellent…

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

Key PointsWall Streets smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all downside…

This GLP-1 Stocks Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk @themotleyfool #stocks $AMGN

…

This Dirt Cheap Healthcare Stock Could Be a Hidden Artificial Intelligence (AI) Opportunity (Hint: Its Not Eli Lilly)

Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.…

Which Stock Will Dominate the Weight Management Market Through 2030?

The market for weight management medicines has been the hottest therapeutic area in the past two years. Plenty of companies…

NVO vs. LLY: Which Obesity Powerhouse is the Stronger Bet Now?

Eli Lilly edges ahead of Novo Nordisk as the stronger obesity bet, backed by robust sales growth, pipeline depth and…

This Vanguard ETF Turned $10,000 Into $108,900 -- and AI Could Accelerate Its Growth

Stocks are on fire this summer. Driven primarily by artificial intelligence (AI) and its offshoots like advanced robotics, tech stocks…

Why This Weight Loss Drug Companys Stock Surged Today

Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move likely…

Eli Lilly: Ive Learned Not To Fight Against The Market (Downgrade)

…